YPrime eCOA in Action: A Pediatric Migraine Study
Pediatric migraine studies demand reliable eCOA for pediatric clinical trials to capture unpredictable symptom onset and patient response. For a global trial spanning over 200 sites with more than 800 participants, a pharmaceutical leader faced persistent challenges when their existing eCOA platform couldn’t support real-time event documentation or offline randomization.
YPrime deployed its pediatric-friendly eCOA platform, tailored to address the specific needs of this complex migraine study. The solution included event-driven assessments, patient-initiated randomization, age-appropriate visual elements, daily check-ins, and visual medication guidance to maintain protocol compliance.
One of the standout features of this study was YPrime’s patient-initiated randomization, which enabled participants to trigger randomization during unexpected migraine events, even when devices were offline. This innovation ensured seamless continuity in study protocol and data collection, regardless of technological limitations.
Key Takeaways: Optimizing eCOA for Pediatric Clinical Trials
Get the Complete Case Study
Complete the form to learn how YPrime eCOA for pediatric clinical trials can effectively support studies with unpredictable events.